Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in AdultsHemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingNot applicable2022-02-18NCT04179929

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
PETHEMA Foundation21

83 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Clínica TeknonBarcelonaSpain1
Complejo Hosp. Univ. de OrenseOurenseSpain1
Complejo Hosp. Univ. Santiago de CompostelaSantiago de CompostelaSpain1
Complejo Hospitalario Ciudad de JaénJaénSpain1
Complejo Hospitalario NavarraPamplonaSpain1
Complejo Hospitalario Pontevedra - Hospital MonteceloPontevedraSpain1
Fundación Jiménez DíazMadridSpain10
H AlbaceteAlbaceteSpain1
H BasurtoBilbaoSpain1
H del MarBarcelonaSpain1
H DonostiaSan SebastiánSpain2
H Dr. NegrínLas Palmas de Gran CanariaSpain1
H GaldakaoGaldakaoSpain1
H Juan Ramón JiménezHuelvaSpain1
H La ZarzuelaMadridSpain1
H Puerta de HierroMadridSpain1
H Río CarriónPalenciaSpain1
H TorrejónTorrejón de ArdozSpain1
H. 12 de OctubreMadridSpain4
H. A CoruñaA CoruñaSpain1
H. Arnau De VilanovaLleidaSpain1
H. Arnau de VilanovaValenciaSpain1
H. Carlos HayaMálagaSpain1
H. Central de AsturiasOviedoSpain1
H. Clínic de BarcelonaBarcelonaSpain3